Tag Archives: VVUS

A Director at Vivus (NASDAQ: VVUS) is Buying Shares

Today, a Director at Vivus (VVUS – Research Report), Eric W. Roberts, bought shares of VVUS for $40.97K. This recent transaction increases Eric W. Roberts’ holding in the company by 104.17% to a total of $79.14K. This is Roberts’ first

Monday’s Highlights at Noon: ImmunoCellular Therapeutics (IMUC), Vivus (VVUS), Terra Tech Corp (TRTC), Rexahn Pharma (RNN), Renesola (SOL)

So far Monday, January 14, NASDAQ is up 0.38% and the S&P is up 1.25%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; ImmunoCellular Therapeutics (IMUC – Research Report), Vivus (VVUS – Research

Tuesday’s Midday Stock Update: Northwest Biotherapeutics (NWBO), Windstream (WIN), Aeterna Zentaris (AEZS), Vivus (VVUS), Petroleo Brasileiro SA- Petrobras (PBR)

So far Tuesday, May 29, NASDAQ is down -1.32% and the S&P is down -1.58%. Here are this morning’s most active stocks: Northwest Biotherapeutics (NASDAQ:NWBO), Windstream (NASDAQ:WIN), Aeterna Zentaris (NASDAQ:AEZS), Vivus (NASDAQ:VVUS) and Petroleo Brasileiro SA- Petrobras (NYSE:PBR). Northwest Biotherapeutics

Wednesday’s Highlights at Noon: Invivo Therapeutics Holdings (NVIV), Acura Pharmaceuticals (ACUR), Vivus (VVUS), Frontier Communications Corporation (FTR), Growlife Inc (PHOT)

So far Wednesday, May 2, NASDAQ is down -0.7% and the S&P is up 0.13%. Here are this morning’s most active stocks: Invivo Therapeutics Holdings (NASDAQ:NVIV), Acura Pharmaceuticals (NASDAQ:ACUR), Vivus (NASDAQ:VVUS), Frontier Communications Corporation (NASDAQ:FTR) and Growlife Inc (Other OTC:PHOT).

Tuesday’s Highlights at Noon: Vivus (VVUS), Acura Pharmaceuticals (ACUR), Terra Tech Corp (TRTC), American Green Inc (ERBB), Biocept Inc (BIOC)

So far Tuesday, May 1, NASDAQ is up 0.42% and the S&P is down -1.53%. Here are this morning’s most active stocks: Vivus (NASDAQ:VVUS), Acura Pharmaceuticals (NASDAQ:ACUR), Terra Tech Corp (Other OTC:TRTC), American Green Inc (Other OTC:ERBB) and Biocept Inc

The CMO of Vivus (NASDAQ: VVUS) is Selling Shares

Today, the CMO of Vivus (NASDAQ: VVUS), Santosh Varghese, sold shares of VVUS for $211. The Company has a book value per share of 121.6418. VVUS’s market cap is $43.14M and the company has a P/E ratio of 1.20. Currently,